Bruker Co. (NASDAQ:BRKR) to Issue Quarterly Dividend of $0.05

Bruker Co. (NASDAQ:BRKR) announced a quarterly dividend on Monday, August 12th, Wall Street Journal reports. Shareholders of record on Monday, September 2nd will be paid a dividend of 0.05 per share by the medical research company on Monday, September 16th. This represents a $0.20 annualized dividend and a yield of 0.33%. The ex-dividend date is Friday, August 30th.

Bruker has increased its dividend by an average of 7.7% annually over the last three years. Bruker has a dividend payout ratio of 6.6% indicating that its dividend is sufficiently covered by earnings. Analysts expect Bruker to earn $3.14 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.4%.

Bruker Price Performance

Shares of Bruker stock traded down $0.24 during trading on Wednesday, hitting $61.13. 213,527 shares of the stock traded hands, compared to its average volume of 1,026,110. The firm’s fifty day moving average is $64.10 and its 200-day moving average is $75.48. The stock has a market cap of $8.88 billion, a price-to-earnings ratio of 22.32, a PEG ratio of 2.39 and a beta of 1.20. Bruker has a 52 week low of $53.79 and a 52 week high of $94.86. The company has a quick ratio of 0.91, a current ratio of 1.81 and a debt-to-equity ratio of 0.95.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 EPS for the quarter, hitting the consensus estimate of $0.52. Bruker had a net margin of 13.38% and a return on equity of 27.31%. The firm had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. During the same period last year, the firm posted $0.50 earnings per share. The business’s revenue was up 17.4% compared to the same quarter last year. Research analysts expect that Bruker will post 2.66 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on BRKR. Citigroup reduced their price objective on Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, July 10th. Bank of America decreased their price target on Bruker from $95.00 to $90.00 and set a “buy” rating on the stock in a research note on Monday, May 20th. Jefferies Financial Group assumed coverage on Bruker in a research note on Monday, June 3rd. They set a “buy” rating and a $85.00 price objective for the company. Stifel Nicolaus decreased their target price on shares of Bruker from $81.00 to $77.00 and set a “hold” rating on the stock in a research note on Monday, May 20th. Finally, StockNews.com lowered shares of Bruker from a “buy” rating to a “hold” rating in a report on Tuesday, May 21st. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $80.80.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.